Acetic Acid

Acetic Acid

SCHEMBL1176751

CC(=O)O.CCOC1c2ccccc2Oc2ccccc21

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.51
KMT2A Q03164 7/20 0.50
MEN1 O00255 5/20 0.50
USP2 O75604 1/20 0.50
POLB P06746 1/20 0.48
PKM P14618 1/20 0.48
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NPC1 O15118 1/20 0.46
CYP2C9 P11712 2/20 0.45
ATM Q13315 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 1/20 0.44
CYP1A2 P05177 2/20 0.44
LMNA P02545 2/20 0.44
CHRM2 P08172 1/20 0.44
CYP2D6 P10635 1/20 0.44
CHRM1 P11229 1/20 0.44
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171011 0.90 KCNA3 (0.56) KCNA3KMT2AMEN1USP2POLB
Benzoic Acid SCHEMBL1723032 0.89 KCNA3 (0.48) KCNA3KMT2AMEN1USP2POLB
SCHEMBL4388824 0.80 KCNA3 (0.54) KCNA3KMT2AMEN1USP2POLB
SCHEMBL7555796 0.76 ATM (0.50) KMT2AMEN1USP2POLBPKM
SCHEMBL11825169 0.75 KCNA3 (0.49) KCNA3KMT2AMEN1USP2POLB
SCHEMBL11831891 0.74 KCNA3 (0.48) KCNA3KMT2AMEN1USP2POLB
SCHEMBL5731331 0.74 ATM (0.52) KCNA3KMT2AMEN1USP2PKM
SCHEMBL3418960 0.74 L3MBTL1 (0.48) KCNA3KMT2AMEN1USP2POLB
SCHEMBL595243 0.73 ATM (0.69) KMT2AMEN1USP2POLBPKM
SCHEMBL7559265 0.73 KMT2A (0.50) KMT2AMEN1USP2POLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861206-B1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR OREAL (FR) 2019-06-12 EP claimed
EP-3386476-A1 COMPOSITION COMPRISING A POLYMER CONTAINING A SULFONIC MONOMER AND A PYRIDINEDICARBOXYLIC ACID DERIVATIVE, AND COSMETIC TREATMENT METHOD L'Oréal (FR) 2018-10-17 EP claimed
WO-2017097849-A1 COMPOSITION COMPRISING A POLYMER CONTAINING A SULFONIC MONOMER AND A PYRIDINEDICARBOXYLIC ACID DERIVATIVE, AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2017-06-15 WO claimed
EP-2861206-A1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR L'OREAL (FR) 2015-04-22 EP claimed
WO-2013186486-A1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR L'OREAL (FR) 2013-12-19 WO claimed
US-20120308671-A1 NASAL OINTMENT BASED ON WHITE PETROLEUM JELLY PHYT-IMMUN GMBH (DE) 2012-12-06 US claimed
EP-1286657-B1 NASAL OINTMENT BASED ON WHITE PETROLEUM JELLY PHYT IMMUN GMBH (DE) 2010-12-29 EP claimed
US-20030161899-A1 Nasal ointment based on white petroleum jelly PHYT IMMUN-GMBH (DE) 2003-08-28 US claimed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US claimed
US-20020082305-A1 Petrolatum-based nose ointment THEISS PETER (DE) 2002-06-27 US claimed
US-20260090977-A1 WATER-IN-OIL COSMETIC COMPOSITION SHINETSU CHEMICAL CO (JP) 2026-04-02 US disclosed
EP-4620455-A1 COSMETIC HAVING CROSSLINKED ORGANOSILOXANE POLYMER SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-24 EP disclosed
CN-107541528-B Saccharomyces veronae fermentation broth of germinated brown rice 株式会社芳珂 2022-09-23 CN disclosed
CN-113318001-A Skin cleanser and lamellar formation promoter containing Trehangelin 株式会社芳珂 2021-08-31 CN disclosed
EP-2861206-B1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR OREAL (FR) 2019-06-12 EP disclosed
US-5932228-A ADMINISTERING BENZOYL PEROXIDE AND COMPOUND THAT REDUCES SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1999-08-03 US disclosed
EP-0787005-A2 DERMATOLOGICAL COMPOSITIONS CONTAINING BENZOYL PEROXIDE AND A COMPOUND REDUCING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1997-08-06 EP disclosed
US-5545407-A ANTIACNE AGENTS THE PROCTER & GAMBLE COMPANY (US) 1996-08-13 US disclosed
WO-1996012498-A2 DERMATOLOGICAL COMPOSITIONS CONTAINING BENZOYL PEROXIDE AND A COMPOUND REDUCING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO disclosed
US-5445823-A Benzoyl peroxide and a compound for reducing skin irritation associated with it THE PROCTER & GAMBLE COMPANY (US) 1995-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090977-A1 WATER-IN-OIL COSMETIC COMPOSITION DEGS1, SQLE, FDFT1 KCNA3 3531/4885KMT2A 4486/4885MEN1 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.